SCHEMBL5823199

SCHEMBL5823199

N#CCCOP

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28583405 0.97
Sulfuric Acid SCHEMBL28661430 0.84 NLRP3 (0.36)
SCHEMBL6891504 0.81 TDP1 (0.35)
SCHEMBL602024 0.81 TDP1 (0.35)
SCHEMBL4745787 0.78 TSHR (0.31)
Morpholine SCHEMBL4366342 0.76 MEN1 (0.41)
SCHEMBL28882280 0.72 ALDH1A1 (0.50)
SCHEMBL193470 0.72
SCHEMBL9411067 0.69
SCHEMBL1263638 0.69 ALDH1A1 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 96 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114678493-A Negative plate and battery 珠海冠宇电池股份有限公司 2022-06-28 CN claimed
CN-109563121-A 5' S-LNA nucleotides and oligonucleotides 罗氏创新中心哥本哈根有限公司 2019-04-02 CN claimed
CN-105985373-A New method for preparing (R)-1,2-di-fatty acid glycerol phosphatidyl glyceride 江苏东南纳米材料有限公司 2016-10-05 CN claimed
JP-3739785-B2 2006-01-25 JP claimed
WO-1998027095-A1 NOVEL PYRROLIZINE DERIVATIVES, THEIR SALTS OR SOLVATES HAVING ANTI-TUMOR ACTIVITY, AND PROCESSES FOR PREPARING THEM GENECHEM INC. (KR) 1998-06-25 WO claimed
EP-0637965-A4 ENHANCED TRIPLE-HELIX AND DOUBLE-HELIX FORMATION WITH OLIGOMERS CONTAINING MODIFIED PYRIMIDINES. GILEAD SCIENCES INC (US) 1996-01-24 EP claimed
EP-0637965-A1 ENHANCED TRIPLE-HELIX AND DOUBLE-HELIX FORMATION WITH OLIGOMERS CONTAINING MODIFIED PYRIMIDINES GILEAD SCIENCES, INC. (US) 1995-02-15 EP claimed
EP-0616612-A4 NUCLEASE STABLE AND BINDING COMPETENT OLIGOMERS AND METHODS FOR THEIR USE. GILEAD SCIENCES INC (US) 1995-01-11 EP claimed
EP-0616612-A1 NUCLEASE STABLE AND BINDING COMPETENT OLIGOMERS AND METHODS FOR THEIR USE GILEAD SCIENCES, INC. (US) 1994-09-28 EP claimed
WO-1993012135-A1 NUCLEASE STABLE AND BINDING COMPETENT OLIGOMERS AND METHODS FOR THEIR USE GILEAD SCIENCES, INC. (US) 1993-06-24 WO claimed
WO-1993010820-A1 ENHANCED TRIPLE-HELIX AND DOUBLE-HELIX FORMATION WITH OLIGOMERS CONTAINING MODIFIED PYRIMIDINES GILEAD SCIENCES, INC. (US) 1993-06-10 WO claimed
US-12428642-B2 Nucleic acid, composition and conjugate comprising the same, preparation method and use thereof Suzhou Ribo Life Science Co., Ltd. (CN) 2025-09-30 US disclosed
WO-2025108284-A1 COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF SODIUM VOLTAGE-GATED CHANNEL ALPHA SUBUNIT 9 (SCN9A) SHANGHAI ARGO BIOPHARMACEUTICAL CO., LTD. (CN) 2025-05-30 WO disclosed
WO-2025077806-A1 COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF MICROTUBULE ASSOCIATED PROTEIN TAU (MAPT) SHANGHAI ARGO BIOPHARMACEUTICAL CO., LTD. (CN) 2025-04-17 WO disclosed
US-12274752-B2 Nucleic acid, composition and conjugate containing same, preparation method, and use thereof Suzhou Ribo Life Science Co., Ltd. (CN) 2025-04-15 US disclosed
WO-1994015619-A1 OLIGONUCLEOTIDES MODIFIED TO IMPROVE STABILITY AT ACID pH THE JOHNS HOPKINS UNIVERSITY (US) 1994-07-21 WO disclosed
WO-1993017717-A1 COMPOSITIONS AND METHODS FOR MODULATING RNA ISIS PHARMACEUTICALS, INC. (US) 1993-09-16 WO disclosed
WO-1993012135-A1 NUCLEASE STABLE AND BINDING COMPETENT OLIGOMERS AND METHODS FOR THEIR USE GILEAD SCIENCES, INC. (US) 1993-06-24 WO disclosed
WO-1993010820-A1 ENHANCED TRIPLE-HELIX AND DOUBLE-HELIX FORMATION WITH OLIGOMERS CONTAINING MODIFIED PYRIMIDINES GILEAD SCIENCES, INC. (US) 1993-06-10 WO disclosed
WO-1991019730-A1 RNA HYDROLYSIS/CLEAVAGE MONSANTO COMPANY (US) 1991-12-26 WO disclosed